No Data
Zimmer Biomet to Present at the Wells Fargo 2024 and Morgan Stanley Annual Global Healthcare Conferences
Zimmer Biomet Holdings Is Maintained at Hold by Canaccord Genuity
CCORF Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Cuts Target Price to $120
Wells Fargo Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $112
Steady Performance and Earnings Stability: A Hold Rating for Zimmer Biomet Holdings
Express News | Zimmer Biomet Holdings Inc : Canaccord Genuity Cuts Target Price to $120 From $130